Nexalin Technology (NXL) Profit After Tax (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Profit After Tax of -$2.1 million for Q1 2026, down 5.45% year-over-year from -$2.2 million in Q1 2025, and up 11.77% quarter-over-quarter from -$2.4 million in Q4 2025.
Nexalin Technology (NXL) Profit After Tax (2021 - 2026) Analysis & Trends
Nexalin Technology's Profit After Tax history runs 6 years deep, the most recent figure standing at -$2.1 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 5.45% year-over-year to -$2.1 million; the TTM figure through Mar 2026 stood at -$8.3 million (up 2.6% YoY), while the FY2025 annual figure was -$8.2 million, down 8.08% from the prior year.
- Profit After Tax for Q1 2026 stood at -$2.1 million, up from -$2.4 million in the prior quarter.
- The five-year high for Profit After Tax was -$135401.0 in Q3 2022, with the low at -$2.8 million in Q4 2024.
- The 5-year median for Profit After Tax is -$1.3 million (2024), against an average of -$1.4 million.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax surged 92.48% in 2022, then plunged 1620.43% in 2023.
- Nexalin Technology's Profit After Tax stood at -$693364.0 in 2022, then fell by 12.77% to -$781874.0 in 2023, then plunged by 262.38% to -$2.8 million in 2024, then increased by 16.13% to -$2.4 million in 2025, then grew by 11.77% to -$2.1 million in 2026.
- Business Quant data shows NXL's Profit After Tax at -$2.1 million in Q1 2026, -$2.4 million in Q4 2025, and -$2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 241.90 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 573.00 Mn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 619.54 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Nexalin Technology | 7.11 Mn | 6.11 Mn | 8,897.00 | -2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.24 Mn |
| Mar 31, 2026 | -2.10 Mn |
| Dec 31, 2025 | -2.38 Mn |
| Sep 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.99 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Sep 30, 2024 | -2.45 Mn |
| Jun 30, 2024 | -1.28 Mn |
| Mar 31, 2024 | -1.04 Mn |
| Dec 31, 2023 | -781,874.00 |
| Sep 30, 2023 | -2.33 Mn |
| Jun 30, 2023 | -830,417.00 |
| Mar 31, 2023 | -707,345.00 |
| Dec 31, 2022 | -693,364.00 |
| Sep 30, 2022 | -135,401.00 |
| Jun 30, 2022 | -462,405.00 |
| Mar 31, 2022 | -393,249.00 |
| Dec 31, 2021 | -595,928.00 |
| Sep 30, 2021 | -1.80 Mn |